Table 3.
Type-specific HPV prevalence and overall prevalence of HPV cell -based detection in healthy women from mainland, stratified by cervical disease grade
| HPV type | NILM | ASCUS | LSIL | ≥HSIL |
|---|---|---|---|---|
| HPV ration | 12.5 (8.9,16.1) | 42.2 (21.5,63.0) | 73.6 (59.9,87.2) | 90.1 (83.6,96.7) |
| HR-HPV | 11.9 (9.8,14.1) | 28.3 (7.9,48.8) | 64.7 (41.8,87.7) | 69.4 (24.2,90.7) |
| LR-HPV | 2.6 (0.8,4.4) | 1.4 (0.0,2.8) | 8.3 (1.7,15.1) | 7.2 (0.8,13.6) |
| HPV6/11 | 2.1 (1.2,3.0) | 4.5 (3.2,5.8) | 5.4 (2.5,8.2) | 3.4 (1.4,5.3) |
| HPV16 | 3.3 (2.0,4.6) | 12.2 (5.9,18.5) | 14.5 (9.5,19.5) | 54.5 (19.2,60.1) |
| HPV52 | 4.1 (2.6,5.5) | 11.4 (5.5,17.3) | 14.1 (7.2,21.0) | 13.5 (5.9,15.5) |
| HPV18 | 1.2 (0.7,1.8) | 4.6 (1.5,7.7) | 6.4 (4.7,8.1) | 12.3 (3.2,18.9) |
| HPV58 | 2.1 (1.3,2.8) | 7.1 (2.7,11.4) | 10.8 (5.1,16.4) | 9.3 (2.8,13.8) |
| HPV59 | 0.5 (0.2,0.7) | 1.2 (0.3,2.2) | 2.3 (1.4,3.3) | 6.9 (2.5,11.3) |
| HPV33 | 0.8 (0.5,1.1) | 2.5 (1.7,3.2) | 8.0 (3.9,12.0) | 6.2 (4.6, 9.4) |
| HPV51 | 1.1 (0.7,1.6) | 3.9 (1.3,6.6) | 9.0 (6.5,11.5) | 6.0 (0.7,7.2) |
| HPV31 | 0.7 (0.4,1.0) | 3.3 (1.6,5.0) | 3.5 (2.0,5.0) | 4.6 (1.5, 4.7) |
| HPV56 | 0.6 (0.4,0.9) | 1.9 (1.1,2.8) | 6.8 (3.0,10.6) | 3.9 (1.3,6.6) |
| HPV45 | 0.7 (0.3,1.1) | 1.9 (0.3,3.6) | 3.7 (0.8,6.6) | 3.5 (1.9,5.1) |
| HPV42 | 0.4 (0.1,0.6) | 0.7 (0.1,1.4) | - | 3.0 (0.1,15.8) |
| HPV39 | 1.0 (0.6,1.5) | 3.5 (1.1,5.9) | 6.2 (4.2,8.2) | 2.7 (1.2,4.1) |
| HPV66 | 1.1 (0.6,1.6) | 4.0 (2.3,5.6) | 7.6 (5.8,9.3) | 2.4 (0.6,4.2) |
| HPV11 | 0.6 (0.2,0.9) | 1.2 (0.5,1.9) | 2.2 (1.2,3.2) | 2.1 (0.7,4.9) |
| HPV35 | 0.5 (0.2,0.7) | 1.3 (0.4,2.2) | 2.7 (0.4,5.1) | 1.6 (0.3,2.8) |
| HPV6 | 0.3 (0.1,0.5) | 3.2 (2.1,4.3) | 4.4 (3.0,5.8) | 1.6 (0.4,2.8) |
| HPV68 | 0.9 (0.6,1.3) | 2.2 (1.5,2.9) | 4.2 (1.8,6.6) | 1.2 (0.2,2.3) |
NILM: No intraepithelial lesion or malignant cells; ASCUS: Atypical squamous cells of undermined significance; LSIL: Low-grade squamous intraepithelial lesion;≥HSIL: High-grade squamous intraepithelial lesion and cancer. HR-HPV:high-risk human papillomavirus,LR-HPV:-risk human papillomavirus